029780.KS - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 60/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

6/7 High

6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).

Beta (Market Relation)

0.23x

Defensive

Volatility (5Y p.a.)

24.5% p.a.

5-Year Horizon

Max Drawdown (5Y)

-38.9%

5-Year Horizon

Sharpe Ratio

0.04

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y)

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-18.7%
3 Years	29.0%	-38.9%	0.27	+10.4%
5 Years	24.5%	-38.9%	0.04	+3.5%
10 Years	25.5%	-54.0%	-0.17	-1.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 261%.

Strong cyclicality: The business model is sensitive to economic downturns.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (29.0%) is noticeably higher than the 5Y average (24.5%).

Historical Stress Test: Maximum peak-to-trough drawdown of -54.0% in the extended horizon.